Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00664755 · ClinicalTrials.gov registry record · Phase 2

Menstrual Cycle Effects on Smoking Cessation and Cue Reactivity

A Phase 2 study of Nicotine Dependence, sponsored by Medical University of South Carolina.

Completed
Registry status
Phase 2
Development phase
140
Enrollment target
1
Study location

NCT00664755 is a Phase 2 study of Nicotine Dependence that has completed, run by Medical University of South Carolina. The registered enrollment target is 140 participants, below the 185-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00664755, a Phase 2 study of Nicotine Dependence, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
Phase 2
Development phase
140 participants
Enrollment target
1
Study location

Study Summary

This is a brief smoking cessation trial in women, comparing transdermal nicotine patch (TNP) versus varenicline.

Conditions Studied

Nicotine Dependence

Interventions

  • DRUG varenicline
  • DEVICE transdermal nicotine patch

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2007-07
Est. Completion 2013-12
Phase Phase 2

Sponsor

Medical University of South Carolina

755 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00664755

The ClinicalTrials.gov registry entry for NCT00664755 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 185-participant average among 67 other Nicotine Dependence trials with a reported enrollment target (24% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Nicotine Dependence appearing as the primary indexed condition, and to 2 interventions - of which varenicline is the first listed.

NCT00664755 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT00664755 about?

NCT00664755 is a clinical study titled "Menstrual Cycle Effects on Smoking Cessation and Cue Reactivity". This is a brief smoking cessation trial in women, comparing transdermal nicotine patch (TNP) versus varenicline.

What is the current status of trial NCT00664755?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 140 participants. The study started on 2007-07. Estimated completion is 2013-12.

What conditions does trial NCT00664755 study?

This clinical trial studies the following conditions: Nicotine Dependence.

What interventions are being tested in trial NCT00664755?

The interventions under investigation include: varenicline (DRUG), transdermal nicotine patch (DEVICE).

Who is sponsoring clinical trial NCT00664755?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00664755 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Nicotine Dependence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Nicotine Dependence

All registered trials for this condition

South Carolina

All trials with a study site in South Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.